Visit AbGenomics International

Developer of antibody therapeutics designed for the treatment of cancer and immune-related inflammatory diseases. The company's antibody therapeutics focus on the discovery and development of novel therapeutics for unmet medical needs in the field of antibody-drug conjugates (ADC) therapy as well as creates a linker-payload that can be utilized for different targeted tumor indications, providing patients with long term drug-free remission of other immune-mediated diseases.